莫利纳医疗 MOH
$208.99 −$7.65 (-3.53%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $208.99 0.00%
开盘$212.84
昨收$216.64
当日区间$206.62 – $219.00
成交量696.4K
市值$10.91B
市盈率（TTM）–
股息率–
财报
财报日平均波动±9.5%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+17.7%
最差反应-25.5%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 21 Oct 2026 | After Market | ±11.4% | +0.81% | 符合区间 |
| 2026/Q2 | 22 Jul 2026 | After Market | ±14.4% | -9.67% | 符合区间 |
| 2026/Q1 | 22 Apr 2026 | After Market | ±13.7% | +14.18% | 超出定价预期 |
| 2025/Q4 | 5 Feb 2026 | After Market | ±13.8% | -25.51% | 超出定价预期 |
| 2025/Q3 | 22 Oct 2025 | After Market | ±14.5% | -17.49% | 超出定价预期 |
| 2025/Q2 | 23 Jul 2025 | After Market | ±14.5% | -16.84% | 超出定价预期 |
| 2025/Q1 | 23 Apr 2025 | After Market | ±10.3% | -5.48% | 符合区间 |
| 2024/Q4 | 5 Feb 2025 | After Market | ±9.3% | -10.09% | 超出定价预期 |
| 2024/Q3 | 23 Oct 2024 | After Market | ±14.1% | +17.67% | 超出定价预期 |
| 2024/Q2 | 24 Jul 2024 | After Market | ±10.8% | +12.28% | 超出定价预期 |
| 2024/Q1 | 24 Apr 2024 | After Market | ±6.8% | -4.11% | 符合区间 |
| 2023/Q4 | 7 Feb 2024 | After Market | ±6.0% | +5.35% | 符合区间 |
| 2023/Q3 | 25 Oct 2023 | After Market | ±8.1% | -1.50% | 符合区间 |
| 2023/Q2 | 26 Jul 2023 | After Market | ±7.2% | -1.23% | 符合区间 |
| 2023/Q1 | 26 Apr 2023 | After Market | ±7.1% | +7.75% | 超出定价预期 |
| 2022/Q4 | 8 Feb 2023 | After Market | ±5.8% | -1.90% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q3 季度
按业务线
基本面
最新报告季度：Q3, ended Sep 2026
营收$11.08B-3.4% YoY
营业利润$106.00M-22.6% YoY
净利润$38.00M-51.9% YoY
摊薄每股收益$0.73-51.7% YoY
自由现金流-$196.00M-20.2% YoY
经营现金流-$159.00M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率8.0%
营业利润率0.6%
净利率-0.1%
净资产收益率-1.2%
资产收益率-0.3%
投入资本回报率1.0%
流动比率1.69
负债/资产比率73.5%
现金及投资$8.58B
总负债$3.95B
净现金（净负债）$4.63B
自由现金流/营收0.5%
暂无评论——快来第一个聊聊 MOH。
登录后参与讨论。